Rita Nanda, MD and Nan Chen, MD headshot

3rd Annual University of Chicago Multidisciplinary Breast Cancer Symposium

Chicago, IL US
March 6, 2026
Elevate breast cancer care across every stage of treatment and survivorship!
 
Join us for a dynamic, case-based symposium to improve the lives of patients living with breast cancer. Expert faculty will share the latest evidence-based strategies in medical, surgical, reconstructive, and radiation oncology, along with insights into practice-changing advances from the past year.

Highlights include:
  • Best practices and current controversies in breast cancer management
  • Cutting-edge applications of ctDNA and liquid biopsy technologies
  • Effective solutions for challenging side effects, including sexual dysfunction, hair loss, and lymphedema
  • A look ahead at late-phase therapies poised for clinical adoption

By the end of this highly interactive activity, you’ll walk away with practical tools to sharpen your decision-making, enhance clinical performance, and deliver better outcomes for patients across all breast cancer subtypes.

Don’t miss this opportunity to stay at the forefront of breast cancer care. Register today!
 
Learn more at the symposium website!

Target Audience

This activity is designed for physicians and other healthcare professionals caring for patients with breast cancer.

Learning Objectives

After this activity, participants will be able to:

  • Apply evidence-based approaches to the use of ctDNA and liquid biopsy in clinical decision-making for patients with breast cancer.
  • Implement supportive care strategies to address sexual dysfunction, hair loss, and lymphedema in breast cancer survivors.
  • Analyze practice-changing developments from the past year to guide clinical decision-making across medical, surgical, and radiation oncology.
  • Integrate recent late-phase clinical trial data to develop patient-specific treatment strategies in breast cancer management.
  • Evaluate evolving surgical strategies, including axillary de-escalation, to optimize outcomes and inform individualized patient care.
  • Develop management plans for toxicities associated with novel breast cancer therapies, including antibody-drug conjugates and endocrine therapies.
  • Design individualized care plans for patients with complex or guideline-limited breast cancer presentations using case-based clinical reasoning.
Additional information
ACGME/ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
For more information, please contact:
CME Coordinator Contact Name: 
Meeting Achievements
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
(219) 465-1115
AttachmentSize
Image icon Symposium Postcard3.28 MB
Summary
Available credit: 
  • 5.25 ABIM Medical Knowledge
  • 5.25 AMA PRA Category 1 Credit™
  • 5.25 Nursing Contact Hours
  • 5.25 Participation
Event starts: 
03/06/2026 - 10:00am
Event ends: 
03/06/2026 - 5:00pm
Activity opens: 
08/28/2025
Activity expires: 
06/06/2026
FRIDAY, MARCH 6, 2026
10:00 am–10:50 amRegistration and Refreshments
10:50 am–11:00 amWelcome
11:00 am–12:00 pmTRACK 1: ONCOLOGY PROVIDER TRACK
Challenging Cases
Betty Fan, DO; Nora Jaskowiak, MD; Fred Howard, MD; Olwen Hahn, MD; Rita Nanda, MD
TRACK 2: PRIMARY CARE PROVIDER TRACK
Toxicities of Breast Cancer Therapy
Joly Raju, NP; Amanda Krug, PA; Hannah Gielczyk, NP; Heng Yang, PharmD; Lauren Olalde, RN
12:00 pm–1:00 pmLunch and Exhibits
1:00 pm–2:00 pmKEYNOTE LECTURE
The Emerging Role of ctDNA in Breast Cancer
Daniel Stover, MD
2:00 pm–3:00 pmTRACK 1: ONCOLOGY PROVIDER TRACK
Surgical Management of Breast Cancer
Sarah Shubeck, MD, MS
Breast Reconstructive Surgery
Maureen Beederman, MD
Radiation Oncology Updates
Steven Chmura, MD, PhD
Q&A
TRACK 2: PRIMARY CARE PROVIDER TRACK
HER2-Positive Breast Cancer
Sarah Poland, MD
Triple-Negative Breast Cancer
Frederick Howard, MD
Hormone Receptor-Positive Breast Cancer
Maeve Hennessy, MD
Q&A
3:00 pm–4:00 pmTRACK 1: ONCOLOGY PROVIDER TRACK
Triple-Negative Breast Cancer
Frederick Howard, MD
HER2-Positive Breast Cancer
Sarah Poland, MD
Hormone Receptor-Positive Breast Cancer
Maeve Hennessy, MD
Q&A
TRACK 2: PRIMARY CARE PROVIDER TRACK
Surgical Management of Breast Cancer
Sarah Shubeck, MD
Breast Reconstructive Surgery
Maureen Beederman, MD
Radiation Oncology Updates
Steven Chmura, MD, PhD
Q&A
4:00 pm–4:15 pmRefreshment Break
4:15 pm–5:30 pmSUBSPECIALTY CARE OF BREAST CANCER PATIENTS
Management of Sexual Side Effects of Breast Cancer Therapy
Maryam Siddiqui, MD
Hair Loss and Breast Cancer Therapy
Victoria Barbosa, MD & Ananya Eeraveni
Lymphedema Management
Scott Grumeretz, PT, DPT, CLT
Genetic Testing Considerations in Breast Cancer Patients
Feighanne Hathaway, MS, CGC
Q&A
5:30 pm–5:35 pmConcluding Remarks
5:35 pm–6:00 pmNetworking and Refreshments
Westin Michigan Avenue Chicago
909 N Michigan Ave
Chicago, IL 60611
United States
WANT TO KNOW MORE?
Explore breast cancer care at the University of Chicago via our website! For questions about the symposium, contact Meeting Achievements via e-mail.
 
WESTIN MICHIGAN AVENUE CHICAGO
Experience comfort and convenience at the Westin Michigan Avenue Chicago, located just steps from Michigan Avenue and a short walk to Lake Michigan. Spacious guest rooms feature plush pillowtop beds with premium linens, LCD televisions, and well-appointed bathrooms to help you recharge after a busy day. Enjoy on-site dining, a coffee shop, and a 24-hour business center, along with complimentary Wi-Fi in public areas. Stay active or unwind with the fitness center and spa services, and let the concierge team help make your visit seamless and enjoyable.
 
Reservations
Book your stay today! Reservations can be made beginning at our dedicated booking website

We encourage you to make your reservation early to ensure availability.

Parking
If you are driving, you are welcome to park onsite or find other options in the area.

$38 parking is available for the day of the symposium only! More information is below.

Valet Parking (with in & out privileges)
  • 3–8 hours: $55
  • 8–24 hours or overnight: $83
Self-Parking (875 N. Michigan Ave., formerly the John Hancock Center)
TRAVEL
Discover why Condé Nast Traveler readers voted Chicago the Best Big City in the U.S. for a historic eighth year in a row. To help plan your stay in Chicago, visit Choose Chicago.
 
 
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact Meeting Achievements via email.
 
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, the University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
UNIVERSITY OF CHICAGO FACULTY
Rita Nanda, MD headshot   Rita Nanda, MD
   Associate Professor of Medicine
   Director, Breast Oncology Program
 
 

 
  Nan Chen, MD
  Assistant Professor of Medicine
 
 
 
 


Disclosure Declarations
As a provider accredited by the ACCME, the University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an educational activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships before the start of the activity.

Additionally, the University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Nursing Credit
University of Chicago Medicine is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
 
Participants who successfully complete the entire activity and complete an evaluation form will earn 5.25 contact hours.
 
American Board of Internal Medicine MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
 
Other Participant Credit
Other participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
 
Please note: The credit claiming process will close three months after the activity ends. Requests to claim credit after three months may incur additional fees.
 
Faculty experts seated at a long table for a panel discussion at the University of Chicago Breast Cancer Symposium.
EXHIBIT OPPORTUNITIES AVAILABLE!
Take advantage of a unique opportunity to showcase your company’s products, services, and innovations to a highly engaged audience of clinicians dedicated to advancing breast cancer care. As an exhibitor at this leading symposium, you’ll connect directly with decision-makers across medical, surgical, reconstructive, and radiation oncology fields, professionals shaping the next era of diagnosis, treatment, and survivorship.

Exhibiting offers the ideal platform to share your latest developments, engage with participants during scheduled networking breaks, and gain visibility through program acknowledgments and event materials.

Don’t miss this opportunity to position your company at the forefront of breast cancer innovation and patient-centered care.
 
Download the PDF icon prospectus or contact Meeting Achievements via email or phone at (219) 465-1115. We hope to see you there!
 

Purple flower buds emerging in Millennium Park, Chicago, with the city skyline visible in the background.

HOW TO REGISTER
Please log in or create an account to register. Once logged in, select the registration type that best suits you. For help, follow our PDF icon registration guide.

 
Registration TypeNon-UChicagoUChicago
Physician $150$100
Other Healthcare Professional$75$50
Resident/Fellow$50
Industry$500
 
CANCELLATION POLICY If you cancel your participation in this conference, your registration fee, less a 50% administrative fee, will be refunded when written notification is received by February 6, 2026. No refunds will be made after February 6, 2026.

CLAIMING CREDIT
After the activity, the credit-claiming process will unlock. Return to this page and click on "Complete Activity" to proceed.
Please Note: The credit claiming process will close three months after the activity ends. Requests to claim credit after three months will be subject to additional fees.
 
Please login or create an account to proceed.